Not only PDGF, but also Interleukin-6 (IL-6), endothelin-1 (ET1) and angiotensin II (Ang II) activate the signal transducer and activator of transcription-3 (STAT3), all of which are dysregulated in PAH patients. This evidence concerns the gene IL6 and pulmonary arterial hypertension.